SCHEMBL20747653

SCHEMBL20747653

CCCC(C)(C)C(C)OC(=O)C(C)N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP3A4 P08684 3/20 0.36
TSHR P16473 2/20 0.36
NFKB1 P19838 2/20 0.36
ADRA1A P35348 1/20 0.36
RAB9A P51151 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
PMP22 Q01453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20747630 0.89 SLC15A1 (0.34) LMNAHSD17B10CYP3A4TSHRNFKB1
SCHEMBL20747689 0.88 LMNA (0.36) LMNA
SCHEMBL20747662 0.86 LMNA (0.39) LMNA
SCHEMBL20747726 0.86 LMNA (0.39) LMNA
SCHEMBL20747635 0.86 LMNA (0.37) LMNAHSD17B10CYP3A4TSHRNFKB1
SCHEMBL20747607 0.85 GRIN2D (0.36) LMNACYP3A4NFKB1GRIN2DGRIN3B
SCHEMBL20747771 0.79 SLC15A1 (0.34) LMNAHSD17B10CYP3A4TSHRNFKB1
SCHEMBL20747664 0.77 GRIN2D (0.36) LMNACYP3A4NFKB1GRIN2DGRIN3B
SCHEMBL20747658 0.76 GRIN2D (0.36) LMNACYP3A4NFKB1GRIN2DGRIN3B
SCHEMBL18067510 0.76 GRIN2D (0.36) LMNACYP3A4NFKB1GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208045-B2 Aza-pyridone compounds and uses thereof ALIOS BIOPHARMA, INC. (US) 2019-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208045-B2 Aza-pyridone compounds and uses thereof PNPO, ITPA, PDXK LMNA 2972/4885HSD17B10 3567/4885CYP3A4 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.